Novartis India launches Pluvicto for prostate cancer treatment
Published on: June 15, 2026, 3:09 p.m. | Source: The Economic Times
Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision radiotherapy precisely targets cancer cells, offering a new treatment approach for metastatic prostate cancer. The therapy will be available through select hospitals and nuclear medicine centers across India.
